Home » Topics » Disease categories and therapies » Cancer

Cancer
RSS

Development of CI-1033, an irreversible inhibitor of EGF tyrosine kinase activity

June 29, 2000

Novel kininogen-derived antiangiogenic peptides emerge from joint research program

June 28, 2000

Apoptosis-inducing small molecule targeting Bcl-2 recently identified

June 28, 2000

Further details on pharmacological profile of FE-200486 presented at ENDO 2000

June 28, 2000

Two series of compounds inhibiting ribonucleotide reductase patented by Kyowa Hakko

June 27, 2000

BASF's new signal transduction inhibitors act on protein kinases

June 27, 2000

Novartis and Schering pursue novel therapeutic approach to angiogenic disorders

June 27, 2000

Schering AG to commence phase I clinical study with Oncolym

June 27, 2000

Promycin clinical studies put on hold

June 27, 2000

Marimastat does not meet primary or secondary endpoints in brain cancer trial

June 26, 2000

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for June 18, 2026.
Alicorn synthesizes new AAK1 inhibitors
BioWorld Science
Researchers from Alicorn Pharmaceutical Co. Ltd. and Jiangsu Alicorn Pharmaceutical Co. Ltd. have disclosed crystalline salts of compounds acting as...
CFTX-2034 successfully shows promise for post-bariatric hypoglycemia in preclinical research
BioWorld Science
Researchers from Confo Therapeutics NV presented the preclinical characterization of CFTX-2034, a selective somatostatin receptor subtype 5 (SSTR5) agonist...
Saniona reports preclinical data for SAN-2668
BioWorld Science
Saniona AB has presented preclinical data and its clinical development strategy for its lead clinical candidate, SAN-2668, which is a GABA-A receptor positive...
CC-3 antibody shows antitumoral activity in penile cancer
BioWorld Science
Advanced penile cancer (PeCa) is a rare cancer affecting the genitourinary tract with a 5-year survival rate of about 10% when metastatic. First-line therapies...